Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial

Outcome measures in multimodal rectal cancer trials

(2020) Emmanouil Fokas et al.   LANCET ONCOLOGY

Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer – Results of the international randomized RAPIDO-trial

(2020) Maxime J.M. van der Valk et al.   RADIOTHERAPY AND ONCOLOGY

International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic

(2020) C.A.M. Marijnen et al.   RADIOTHERAPY AND ONCOLOGY

Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12

(2019) Emmanouil Fokas et al.   JOURNAL OF CLINICAL ONCOLOGY

Tumour regression after radiotherapy for rectal cancer – Results from the randomised Stockholm III trial

(2019) Johan Erlandsson et al.   RADIOTHERAPY AND ONCOLOGY

Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study

(2018) Maxime J M van der Valk et al.   LANCET

3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial

(2018) Timothy J Iveson et al.   LANCET ONCOLOGY

Duration of Adjuvant Chemotherapy for Stage III Colon Cancer

(2018) Axel Grothey et al.   NEW ENGLAND JOURNAL OF MEDICINE

Consolidation mFOLFOX6 Chemotherapy After Chemoradiotherapy Improves Survival in Patients With Locally Advanced Rectal Cancer

(2018) Michael R. Marco et al.   DISEASES OF THE COLON & RECTUM

Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting

(2017) Regina G. H. Beets-Tan et al.   EUROPEAN RADIOLOGY

Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial

(2017) Johan Erlandsson et al.   LANCET ONCOLOGY

Long-course oxaliplatin-based preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study

(2016) K. Bujko et al.   ANNALS OF ONCOLOGY

Postoperative chemotherapy in patients with rectal cancer receiving preoperative radio(chemo)therapy: A meta-analysis of randomized trials comparing surgery ± a fluoropyrimidine and surgery + a fluoropyrimidine ± oxaliplatin

(2015) K. Bujko et al.   EJSO

Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial

(2015) Julio Garcia-Aguilar et al.   LANCET ONCOLOGY

Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data

(2015) Anne J Breugom et al.   LANCET ONCOLOGY

Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial

(2014) A. J. Breugom et al.   ANNALS OF ONCOLOGY

Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer†

(2013) T. H. van Dijk et al.   ANNALS OF ONCOLOGY

Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer – the RAPIDO trial

(2013) Per J Nilsson et al.   BMC CANCER

Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04

(2012) Samuel Y. Ngan et al.   JOURNAL OF CLINICAL ONCOLOGY

Anterior resection syndrome

(2012) Catherine LC Bryant et al.   LANCET ONCOLOGY

Competing risks and the clinical community: irrelevance or ignorance?

(2011) Michael T. Koller et al.   STATISTICS IN MEDICINE

Evaluation of Biologic Effective Dose and Schedule of Fractionation for Preoperative Radiotherapy for Rectal Cancer: Meta-Analyses and Meta-Regression

(2010) Gustavo Arruda Viani et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data

(2010) Monique Maas et al.   LANCET ONCOLOGY

A uniform residual tumor (R) classification

(2009) Christian Wittekind et al.   CANCER

Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2)

(2009) Vincenzo Valentini et al.   RADIOTHERAPY AND ONCOLOGY

Randomized Phase III Study Comparing Preoperative Radiotherapy With Chemoradiotherapy in Nonresectable Rectal Cancer

(2008) Morten Brændengen et al.   JOURNAL OF CLINICAL ONCOLOGY

Short-course preoperative radiotherapy with delayed surgery in rectal cancer – A retrospective study

(2008) Calin Radu et al.   RADIOTHERAPY AND ONCOLOGY